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Abstract 
This study investigated whether methylphenidate is effective in improving response 
inhibition in children with Attention Deficit Hyperactivity Disorder (ADHD). 
Children with ADHD were compared with normally developing children on 
measures of response inhibition.  Participants with ADHD were compared across two 
conditions – medicated and unmedicated.  There was no significant difference 
between the inhibitory control of children with and without ADHD.  Children with 
ADHD showed significant improvements in inhibitory control following 
methylphenidate.  The findings of the present study contrast with previous studies 
which document reduced inhibitory control in ADHD, compared with normally 
developing children. Reports of methylphenidate improving functioning in children 
with ADHD are supported.  Limitation and implications of the study are discussed. 
 
Keywords:  ADHD, Response Inhibition, Medication, Methylphenidate, Animal 
Stroop 
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1. Introduction 
Attention Deficit Hyperactivity Disorder (ADHD) is a developmental disorder 
with the cardinal features of developmentally inappropriate levels of sustained 
attention, distractibility, hyperactivity, and impulse control (Barkley, 2000).  It arises 
early in childhood and persists through adolescence and into adulthood in 30-70% of 
cases (Weiss & Murray, 2003).  Current estimates indicate that 3-5% of the 
American population has ADHD (Goldman, Genel, Bezman, & Slanetz, 1998) with 
similar proportions within the UK population of primary-school aged children 
(Taylor, 1999).  ADHD is known to have neuropsychological consequences that are 
evident from psychological tests and measures of school failure (Seidman, 
Biederman, Faraone, Weber, & Ouellett, 1997). As such, the disorder is associated 
with both concurrent and long-term impairments in academic and social functioning 
(Johnston, 1998).  Comorbidity is common in ADHD and a significant proportion of 
those diagnosed go on to develop delinquent activities and antisocial personalities 
(Barkley, 2000).    
Neuropsychological models now consider children with ADHD to have 
difficulties in terms of cognitive attention and executive functioning deficits (e.g. 
Lawrence, Houghton, Tannock, & Douglas 2002).  More specifically, researchers 
have emphasized poor behavioural/response inhibition as the central impairment of 
the disorder (Barkley, 1990). Response inhibition is the ability to inhibit a prepotent 
response, interrupt an ongoing sequence and resist interference (Barkley, 1997) i.e. 
‘to stop (suddenly and completely) a planned or ongoing thought and action’ 
(Williams, Ponesse, Schachar, Logan, & Tannock 1999, pg. 205). 
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Research has demonstrated that children with ADHD show marked impairments 
in inhibitory responses across a variety of tasks (e.g. Booth, Burman, Meyer, Lei, & 
Tronmer, 2005; Halperin, Newcorn, Sharma, Healey, & Wolf, 1990) and a review by 
Pennington and Ozonoff (1996) concluded that executive functioning deficits are 
consistent in ADHD.  In addition, a high proportion of the measures that were found 
to be most sensitive to ADHD were tapping processes of inhibition, suggesting that 
measures of inhibition would appear to be particularly sensitive to ADHD. This 
suggestion is backed up by functional magnetic resonance imaging (fMRI) data 
(Booth et al., 2005; Rubia, Taylor, Smith, Oksannen, & Overmeyer, 2001). Thus, 
there appears to be a wealth of evidence offering support for a response inhibition 
deficit in children with ADHD 
1.1 Treatment for children with ADHD 
While the behavioural difficulties associated with ADHD are often managed 
with psychotherapeutic approaches, there is an absence of positive outcome studies 
(Brown & Levers, 1999).  Instead, a large-scale multi-modal treatment study of 
children with ADHD demonstrated that the most effective treatment for ADHD was 
closely managed pharmacotherapy (MTA Cooperative Group, 1999).  Despite 
several challenges to these findings (e.g. Owens & Hoza, 2003), well-titrated medical 
treatment for ADHD remains the treatment of choice (Hood, Baird, Rankin, & 
Isaacs, 2005). 
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Psychostimulants are the most commonly prescribed psychotropic agent for 
children and typically come in the form of short-acting immediate release stimulants, 
such as methylphenidate.  Methylphenidate is believed to work by influencing the 
processes involved in the uptake and release of dopamine, which is associated with 
motivation and reward (Volkow, Wang, Fowler, Logan, Gerasimov, Maynord, et al., 
2001).  It has been suggested that people with ADHD may have low levels of 
dopamine within the brain and that methylphenidate allows interest in less 
motivating tasks to be maintained, and performance to be improved (Volkow et al., 
2001. Indeed, there is evidence to suggest that stimulant medication significantly 
improves both the classroom and social behaviour of children with ADHD (Pelham, 
1986; Miller, Lee, Raina, Klasses, Zupancic, & Olsen, 1998).  Contentions of 
improved functioning are also supported by the neuropsychological evidence.  In 
comparison to unmedicated ADHD controls, children receiving stimulant treatment 
demonstrate enhanced performance on tests of executive functioning, (Kempton, 
Vance, Maruff, Luk, Costin, & Pantelis, 1999) and attentional processes (Hood et al., 
2005)  
With stimulant medication being recommended as the first-line treatment in 
ADHD (NICE, 2000), and the dominant neuropsychological theory citing response 
inhibition as the cardinal feature in ADHD (Barkley, 1997), it is perhaps 
unsurprising that research has begun to look at the relationship between these factors. 
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1.2 The effects of medication on response inhibition 
Broyd, Johnstone, Barry, Clarke, McCarthy, & Selikowitz (2005) used the 
Go/NoGo task, alongside a number of electrophysiological measures, to examine the 
effects of methylphenidate on response inhibition in children with ADHD. The 
ADHD group were found to make more overall errors (omission and commission) in 
the pre-medication condition.  After receiving medication, the ADHD group still 
made more omission errors than controls, but no longer differed with regard to the 
number of commission errors.  The authors interpreted this as evidence that 
methylphenidate does ameliorate deficits in response inhibition and these 
behavioural findings were further substantiated by the electrophysiological findings 
of reduced skin conductance levels, overall supporting a hypoarousal model of 
ADHD (Broyd et al., 2005). 
Scheres, Oosterlaan, Swanson, Morein-Zamir, & Schut, (2003) investigated 
the effect of methylphenidate and placebo on response inhibition in 23 boys with 
ADHD. Response inhibition was broken down into three components: inhibition of a 
prepotent response, inhibition of an ongoing response, and interference control.  It 
was found that, compared to placebo, inhibitory control did improve with 
methylphenidate. This effect was, however, only significant for inhibition of a 
prepotent response and one of two measure of inhibition of an ongoing response. 
There was no significant effect of methylphenidate on interference control. This 
contrasts with the findings of an earlier study where, in comparison to pre-treatment 
baseline assessment, Stroop performance was reported to have improved following 
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one year of methylphenidate treatment (Everett, Thomas, Cote, Levesque, & 
Michaud, 1991).   
Overall then, the few studies in this area generally suggest that 
pharmacological techniques improve both the behavioural and neuropsychological 
performance of children with ADHD.  There is, however, the need for further 
research which examines the direct effects of medication on response inhibition, 
particularly as   the latter is now widely viewed as the cardinal feature of ADHD 
(Barkley, 1997). 
1.3 Research aims 
The aim of this study is to examine whether methylphenidate is effective in 
improving response inhibition in children with ADHD, using a using the Animal 
Stroop Task (Wright, Waterman, Prescott, & Murdoch-Eaton, 2003).  It was 
hypothesised that: 
1. Children with ADHD will show more impaired response inhibition than 
control participants; 
2. Following their prescribed methylphenidate dose, children with ADHD will 
show an improvement in response inhibition. 
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2. Method 
2.1 Design 
A between subjects design was used to investigate the performance of 
children with ADHD and a control group on a measure of response inhibition.  
Additional within subjects comparisons were made in the group of participants with 
ADHD to compare response inhibition in the ‘medicated’ vs. ‘unmedicated’ 
condition.   
 
2.2 Power Calculation 
A large effect size was posited from previous research (e.g. Pennington & 
Ozonoff, 1996; Scheres et al., 2004).  Based on Cohen’s (1992) estimate of sample 
size (setting power at 0.8 and alpha at 0.05) one-tailed between subjects tests of 
difference would require that N=20, and one-tailed within subjects tests of difference 
would require that N=12.   
2.3 Participants 
Two groups participated in this study, an experimental group of individuals 
with ADHD and a control group of non-ADHD individuals, matched for age, gender 
and IQ.  The age of participants with ADHD ranged from 6-14 (mean CA = 9.3, SD 
= 2.6).  A total of 16 boys and 5 girls participated.  Estimated Full-Scale IQ (FSIQ) 
scores ranged from 62 - 144 (mean FSIQ = 94.3, SD = 18.2).   
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Participants in the control group were 20 boys and 5 girls, aged between 6 – 
13 years (mean CA = 9.2, SD = 2.0).  Estimated Full-Scale IQ scores ranged from 71 
- 132 (mean FSIQ = 102.5, SD = 17.0). Independent samples t-tests, found no 
significant differences between the two groups in relation to age (t(45)=-.020, 
p=0.84) or IQ (t(45)=1.58, p=0.12). A chi-square illustrated no significant difference 
between the distribution of males and females in the two groups (X
2
=0.10
, 
p=0.78).  
 
2.4 Inclusion and exclusion criteria 
Children had to be aged between 5-16 years to be included in the study.  
Children in the experimental condition had to have a primary diagnosis of ADHD 
and be receiving treatment with psychostimulant medication (those receiving non-
methylphenidate based drugs, e.g. Atomoxetine were excluded). Children in the 
control group had no diagnosis of ADHD. Children in both groups were excluded if 
they had a diagnosis of any other significant mental health condition.  
The children in the experimental group were current patients of a rural Child 
and Adolescent Mental Health Service (CAMHS) In Scotland.  They had been given 
a diagnosis of ADHD prior to taking part in the study and all were currently being 
treated with methylphenidate based psychostimulant medication. Diagnostic 
assessment was carried out by a multi-disciplinary team in accordance with Scottish 
Intercollegiate Guidance Network recommendations for assessment for ADHD 
(SIGN, 2001). The methylphenidate dosage received by each participant varied 
dependent on their individual requirements. The length of time that participants had 
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been receiving psychostimulant medication varied from between 4 and 84 months 
(mean = 17.8, SD = 17.3). 
Participants in the control group were recruited from a variety of local 
schools. None of this group had a diagnosis of ADHD or had had previous contact 
with the Child and Adolescent Mental Health Service. 
 
2.5 Description and Application of Measures 
2.5.1 Estimated Full Scale IQ 
Full-scale IQ was estimated using a shortened version of the Wechsler 
Intelligence Scale for Children, UK (WISC-III UK, Wechsler, 1991), comprised of 
one verbal subtest (Vocabulary) and one performance subtest (Block Design).  The 
reliability and validity of this short form is high (r = 0.906) (Sattler, 1992) and it is 
considered to be a good screening combination (Kilian & Hughes, 1978). 
 
2.5.2 Response inhibition 
Response inhibition was measured using the Animal Stroop Task (Wright et 
al., 2003).  This is a relatively new, pictorial modification of the original Colour-
Word Stroop Task (Stroop, 1935) and is based on four exemplar animal stimuli; a 
cow, a pig, a duck and a sheep.  The task comprises three conditions.  The first is an 
‘Incongruent Condition’ where each of the animals’ heads is substituted with a head 
from another of the three animal prototypes.  Thus, within the incongruent condition, 
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there are 12 animal-stroop stimuli.  The second condition is a ‘Matching Condition’ 
where each of the four animal prototypes is displayed as a whole animal - i.e. the 
animal’s body is coupled with the appropriate, matching head.  Lastly, the task 
includes a ‘Control Condition’ where the animal’s head is replaced by a caricature of 
a face.   
The Animal Stroop Task is based on the premise that facial information is 
preferentially processed (Johnson, 1993) and utilized preferentially in semantic 
categorization (Quinn & Eimas, 1996).  Thus, in both the incongruent and control 
conditions, stroop-like interference can be induced by asking the child to name the 
animal’s body and inhibit a preferred response to identify the head (Wright et al., 
2003).  The control task is intended to act as a semantic control in that it contains 
similar semantic content as a face, but produces less activation of animal 
representations.  As such, it is believed to serve as the most appropriate comparison 
with the incongruent task (Wright et al., 2003).   
The Animal Stroop comprises three blocks, with twenty four images in each.  
The first and third blocks consist of a mixture of incongruent and control images – 
twelve of each within a block.  The second block contains ‘matching’ images only.  
In blocks one and three, children are required to name the animal’s body whereas, in 
block two, they are asked to simply name the animal.  The difference between 
reaction times in the incongruent and control conditions (i.e. ‘Reaction Time 
Difference’) is used as a measure of inhibitory control (Wright et al., 2003).  Thus, 
blocks one and three are used to provide a measure of response inhibition. The 
images are presented on a computer screen and displayed in a random order.   
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The present study utilized the procedure outlined above. Before commencing 
the Animal Stroop Task, participants were shown flashcards of each of the four 
animals and asked to name them in order to ensure correct identification.  Following 
this, participants were given verbal task instructions and completed a series of 
‘warm-up’ trials.  An example image was presented at the start of each block 
whereupon the task instructions were repeated.  Participants were required to identify 
the example image correctly before proceeding with the test. 
The accuracy of children’s naming was recorded by the experimenter.  
Reaction times were recorded by ‘voice key’, elicited by the participants’ vocal 
response, with the first author operating a manual timing procedure as back-up.   
 
2.5.3 Strengths and Difficulties Questionnaire (SDQ) 
The Strengths and Difficulties Questionnaire (SDQ) (Goodman, 1997) was used to 
assess levels of hyperactivity in control group participants.  The reliability and 
validity of the SDQ are relatively good and, as such, it is considered as a useful, brief 
measure of the adjustment and psychopathology of children and adolescents 
(Goodman, 2001).  Questionnaires were completed for each participant in the control 
group - either by their parent(s) or classteacher.  All participants in the control group 
scored within the ‘normal’ range with regard to ‘hyperactivity/inattention’.  
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2.6 Procedure 
All participants were tested on a one-to-one basis by the first author.  Each 
participant in the experimental group was assessed under a ‘medicated’ condition 
where they had taken their prescribed stimulant medication as usual and an 
‘unmedicated’ condition where they were assessed following an unmedicated period 
of at least 12 hours.  This time period was chosen in consultation with the Consultant 
Psychiatrist attached to the CAMHS and ADHD Service.  This was on the basis that 
missing a single dosage of routinely prescribed medication was unlikely to have any 
significant adverse effects as, due to the relatively short half-life of stimulant 
medications, children prescribed these treatments often experience a dip in 
medication level during
 
some points of the day (Pelham, Gnagy, Burrows-Maclean, 
Williams, Fabiano, & Morrisey, 2001).  The 12 hour time period was also considered 
sufficient for slower release methylphenidate preparations, such as Concerta, which 
are designed to last 12 hours.   
Equal numbers of participants were allocated to the ‘medicated’ or ‘unmedicated’ 
conditions initially and the condition-type was reversed for their second assessment 
session.  The period of time between assessment sessions varied for each participant 
and ranged from between four and fourteen days (mean = 6.8, SD = 2.0). Participants 
in the control group were assessed on only one occasion. 
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3. Results 
Data which were not normally distributed was transformed using a natural 
logarithm (x+1) transformation. The data were subsequently analysed using 
parametric tests. The significance level of test results, unless otherwise stated, was 
set at p=0.05 (one-tailed). 
 
3.1 Exploratory Data Analysis 
Two participants were removed from each of the ADHD group (medicated 
condition) and the Control group due to outlier scores on the inhibitory control 
measure of the Animal Stroop.  There were no outliers in the ADHD-unmedicated 
condition. 
 
3.2 Test order effects 
An ANOVA was used to examine whether there was any effect of the order 
in which the experimental participants were tested (i.e. whether they were in the 
medicated followed by unmedicated condition or vice versa).  The ANOVA showed 
there was no interaction between order and group (F = 0.83, p = 0.37, df = 1) on 
Reaction Time Difference scores. The ‘order’ variable was therefore removed from 
further analysis.  
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3.3 Hypothesis 1 
Independent Samples t-tests showed no significant differences in Reaction 
Time Difference Scores between either the ADHD-medicated and control groups 
(t(44) = -0.98, p = 0.17) or between the ADHD-unmedicated and control groups 
(t(40) = 1.56, p = 0.06).  Table 1 illustrates the mean reaction time difference scores.   
INSERT TABLE 1 ABOUT HERE 
3.4 Hypothesis 2 
A Paired-Samples t-test showed a significant difference between the reaction 
time difference scores of participants with ADHD-medicated and participants with 
ADHD-unmedicated (t(18) = 2.28, p = 0.02).  ADHD participants showed 
significantly higher reaction time difference scores in the unmedicated condition 
compared to the medicated condition (see table 1). 
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4. Discussion 
The present study examined the impact of methylphenidate on response 
inhibition in children with ADHD, using the Animal Stroop Task (Wright et al., 
2003). No significant differences in Reaction Time Difference Scores were found 
between either the ADHD-medicated and control group or between the ADHD-
unmedicated and control group, although the latter was approaching significance. 
This indicates that children with ADHD (irrespective of whether they are being 
treated with methylphenidate medication) do not differ from children without ADHD 
with regard to their level of inhibitory control, as measured by the Animal Stroop 
Task.   
This result is inconsistent with the now wide-spread theory of response inhibition 
as the central deficit of ADHD (Barkley, 1997) and with previous research which 
contends that, in comparison to controls, children with ADHD have significant 
impairments in inhibitory responses across go/no-go tasks (e.g. Booth et al., 2005), 
the continuous performance task (Halperin et al., 1990), the stop signal task 
(Schachar & Logan, 1990) and Stroop interference tasks (e.g. Hougton et al., 1999).  
Many of these tasks, however, comprise pure measures of motor inhibition and may 
fail to tap into inhibitory control more broadly e.g. across a cognitive and 
behavioural level (Wright et al., 2003).  By contrast, the Stroop tasks rely on vocal 
responses which may make higher demands on inhibitory control in general.  Some 
studies using the colour-word version of the Stroop task often fail to find 
impairments in response inhibition in children with ADHD (e.g. Kerns, McInerney, 
& Wilde, 2001; vanMourik, Oosterlaan,  & Sergeant, 2005).  Such results could be 
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interpreted as evidence that, once the motor component of response inhibition is 
removed, children with ADHD do not display any deficit in inhibitory control.  Other 
researchers have, however, demonstrated such deficits by using the same Stroop task 
(e.g. Houghton, Douglas, West, Whiting, Wall, Langsford et al., 1999; Pennington & 
Ozonoff, 1996), although, given the high rates of co-morbidity between ADHD and 
reading disorder (August & Garfinkel, 1990), the fact that many of these studies fail 
to control for reading ability has been put forward as a possible explanation for these 
conflicting results (vanMourik et al., 2005).  However, measures such as the Animal 
Stroop task, which use pictorial images rather than words, should be devoid of such 
shortcomings. 
As such, the failure of the current study to find an inhibitory control deficit in 
children with ADHD may be more representative of Kerns et al.’s (2001) contentions 
that different tasks may tap different components of inhibition and that not all levels 
of inhibition are necessarily impaired in children with ADHD (Kerns et al., 2001).  
Thus it is possible that inhibitory control, as measured by the Animal Stroop, might 
not be affected by ADHD.  It may then have been useful for this study to have 
employed more than one measure of inhibitory control in order to assess the potential 
for different components of inhibition more thoroughly. 
Alternatively, these results may have relevance for the ‘delay aversion’ 
hypothesis put forward by Sonuga-Barke, Williams, Hall, & Saxton, (1996).  This 
argues that the cognitive deficits thought to be shown by children with ADHD could 
actually be more motivational in nature, i.e. children with ADHD are averse to delay.  
Sonuga-Barke et al. (1996) highlighted that studies measuring inhibitory control are 
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often effected by trial constraints (i.e. as soon as one trial ended another began) and, 
therefore, are confounded with delay.  When these experiments have been repeated 
in such a manner that early or impulsive responses have no influence on delay, the 
responses from children with ADHD are comparable with those of controls (Sonuga-
Barke et al., 1996).  The trials in the Animal Stroop Task are of equal length, 
irrespective of participant’s speed of responding.  Thus, the current lack of 
discrepancy between the inhibitory control of children with ADHD and children in 
the control group may be due to the fact that, as participants could not opt to 
minimise the delay by acting more impulsively, there was little motivational 
incentive for children with ADHD to respond more rapidly. 
Nonetheless, these explanations fail to account for the initial findings of Wright 
et al. (2003) who, with reference to the behavioural data of a large sample of children 
aged between 3 and 16 years, suggested that the Animal Stroop appeared to identify 
those at risk of hyperactive symptomatology (Wright et al., 2003).  It should be 
noted, however, that Wright et al’s (2003) findings were based on data gathered from 
a school-based sample and only utilised behavioural data gathered from teachers 
rather than the cross-situational information required in considering a diagnosis of 
ADHD.  Thus, the contrast in findings with those of the current study may suggest 
that using the Animal Stroop task as a measure of inhibitory control is not sufficient 
in differentiating between children with a clinical diagnosis of ADHD and normally 
developing children.  
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Despite this, children with ADHD showed significant improvements in inhibitory 
control after receiving their methylphenidate medication, supporting previous reports 
of methylphenidate ameliorating deficits in response inhibition (Broyd et al., 2005; 
Everett et al., 1991), classroom and social behaviour of children with ADHD (Miller 
et al., 1998; Pelham et al., 1998), performance on attentional measures (Hood et al., 
2005) and various other executive functioning tasks (Kempton et al., 1999). 
Horrobin, McNair, Kirk, & Waldie (2007) suggest a mechanism for this. Their case 
study of an adult with ADHD suggested that dexamphetamine improved interference 
control on a Stroop task. This was indicated by the fact that, when on medication, the 
individual’s event-related potentials (as measured by electroencephalography) for the 
incongruent condition closely resembled those of the control participant, with a 
concurrent improvement in reaction times and accuracy.   
Scheres et al. (2003), however, found that while methylphenidate produced 
significant improvements in the inhibition of a prepotent response and partial 
improvements in the inhibition of an on-going response, there was no significant 
effect of methylphenidate on interference control (as measured by both the Stroop 
Colour-Word Test and the Eriksen Flanker Task).    
The differing results may have been due to Scheres et al. (2003) not directly 
controlling for reading ability or to the differing levels of methylphenidate received 
by the children in each study.  Scheres et al. (2003) examined the effects of 
methylphenidate dose specifically up to a 20mg dose and found no effects of 
medication dosage on any of the response inhibition measures.  Many of the children 
with ADHD in the current study were, however, receiving doses of methylphenidate-
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based medication that exceeded a 20mg dose.  Indeed, other studies have reported an 
optimal response to medium or high doses of methylphenidate in cognitive tasks 
(e.g., Douglas, Barr, Amin, O'Neill, & Britton, 1988), yet Tannock, Schachar, and 
Logan, (1995) found that inhibitory performance declined in their high dose 
condition compared to the medium dose condition.  In contrast, a study by Rapport 
and Kelly (1991) which examined the effects of low and high doses of 
methylphenidate on cognitive tasks reported there was no evidence to support an 
optimal lower dose.  Due to the different methylphenidate-based prescriptions 
received by the children with ADHD in the current study (e.g. long- vs. short-acting 
preparations), along with the various timings at which these were taken, it was not 
possible to accurately control for the effects of methylphenidate dosage.  Thus, it is 
not possible to ascertain whether the dosage level of methylphenidate had an effect 
on the inhibitory control of participants with ADHD. 
It may also be of note that all participants within the experimental group of the 
current study had been receiving medication for a minimum period of 4 months.  
This is in contrast to some of the previous research in which participants are naïve to 
medication and subsequently experience a period of titration before the study 
commences.  Although these titration periods are relatively extensive (e.g. four 
weeks in the case of Scheres et al., 2003), it is possible that the length of time 
participants have been receiving medication has an effect on any subsequently 
experienced improvements in response inhibition.  Indeed, while Scheres et al. 
(2003) found no improvement in response inhibition following methylphenidate 
administration, others have reported significant improvements in the inhibitory 
control (as measured by the Stroop Colour-Word Test) of hyperactive children 
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following a year of treatment with methylphenidate (Everett et al., 1991).  Again, due 
to the wide range in the length of time that participants had been receiving 
psychostimulant medication (i.e. between 4 and 84 months) and changes in 
medication  dose and type  that had occurred within this time, alongside the different 
doses and types of medication prescribed presently, it was not possible to accurately 
control for the length of time on medication in the current study. 
 
4.1 Methodological Considerations 
As was noted one limitation of the current study was the inability to control 
for type, dosage and length of time on medication. The study had a number of 
additional limitations. In terms of measures, the Animal Stroop had the advantages of 
being a reliable and valid measure of inhibitory control (Wright et al., 2003) and, 
being pictorial-based, it did not require a certain level of reading ability in order to 
yield reliable scores.  Wright et al. (2003), however, warn that the Animal Stroop 
may be a less sensitive measure of impulse control in older children. It is possible 
that ceiling effects amongst the older participants in the present study may be 
masking a difference between the inhibitory control of participants with and without 
ADHD. 
In addition, while the hyperactivity/inattention questions of the SDQ were 
used with the control group, this only provides a broad screening. While none of the 
children in this group were identified by teachers as having behaviours indicative of 
ADHD or indeed were known to CAMH services, failure to carry out diagnostic 
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assessments means the possibility that some of the children in the control group had 
ADHD can’t be ruled out.  
Another limitation in relation to participant diagnosis is that ADHD 
encompasses three subtypes – ‘inattentive’, ‘hyperactive-impulsive’, and ‘combined’ 
ADHD (Rappley, 2005).  While all participants in the ADHD group had been given 
the diagnosis by a multi-disciplinary team, they had not been classified as a 
particular subtype and, as such, the current study did not take into account the 
potential influence of different subtypes on performance.  As the ADHD group did 
not complete the SDQ, a broad subtype classification could not even be made on this 
basis. Nonetheless, classifying participants with ADHD into the different subtypes 
can be problematic and not always easy to define.  For instance, children in either the 
inattentive or hyperactive-impulsive subtype may be just one symptom below the 
threshold for the combined subtype, thus specific subtypes may be contaminated by 
contrasting features of another subtype (vanMourik et al., 2005). Finally, there were 
limitations in terms of sample size. While the required number of participants were 
recruited to achieve statistical power overall, two participants were removed from 
each of the ADHD group (medicated condition) and the Control group due to outlier 
scores on the inhibitory control measure of the Animal Stroop.  While these scores 
needed to be removed in order for the groups to be matched on the inhibitory control 
task, it meant that in analyses examining inhibitory control, the number of 
participants within the medicated condition of the experimental group was one short 
of that required to reach statistical power.  
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4.2  Clinical Implications 
The current study highlights the need to monitor the effects of medication 
treatments on response inhibition.  Whether medication is improving a child’s ability 
to control their inhibition is an important area as such improvements may aid them in 
other areas of development, such as attentional ability, social skills etc. (Tannock, 
Schachar, Carr, Chajczyk, & Logan, 1989).  Conversely, monitoring the symptoms 
of ADHD is also important when we consider the abundance of negative 
consequences that can develop from the disorder, such as conduct disorder (Taylor, 
Chadwick, Heptinstall, & Danckaerts, 1996).  In clinical practice, the effects of 
medication on children with ADHD are monitored in relation to their effects on 
observed behaviour.  These observations, however, can be fairly subjective and may 
not pick up improvements in response inhibition.  Neuropsychological tests, such as 
the Animal Stroop (Wright et al., 2003), may provide another means of monitoring 
the potential effects of medication on response inhibition.  However, the lack of 
significant difference between the inhibitory control of children with ADHD 
(irrespective of medication status) and children in the control group found in the 
present study suggests that further research is required into the Animal Stroop Task 
as a potential screening measure to identify children at risk of hyperactive 
symptomatology.      
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5. Conclusion 
The present research used the Animal Stroop Task (Wright et al., 2003) to examine 
whether methylphenidate-based medication is effective in improving inhibitory control in 
children with ADHD.  The study found that methylphenidate improved the inhibitory 
control of children with ADHD, however, no significant differences between the 
inhibitory control of children with ADHD (irrespective of medication status) and children 
in the control group were found.  This result contrasts with a considerable amount of 
evidence documenting deficits in the inhibitory control of children with ADHD, however, 
may provide support for contentions that different tasks tap different components of 
inhibition and that not all levels of inhibition are necessarily impaired in children with 
ADHD (Kerns et al., 2001).  Alternatively, it may offer support for the ‘delay aversion’ 
hypothesis in which cognitive deficits in children with ADHD are thought to be more 
motivational in nature (Sonuga-Barke et al., 1996). 
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Table 1:   Means, Ranges and Standard Deviations for the experimental and control 
groups 
 ADHD-Medicated 
(n=19) 
ADHD- Unmedicated 
(n=21) 
Control 
(n=23) 
Mean SD Range Mean SD Range Mean SD Range 
Reaction 
time  
difference 
39.95 58.6 -66 to 
141 
103.86 103.02 -66 to 
298 
76.57 86.99 -80 to 
262 
 
 
 
